Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar(St. Jude Children's Research Hospital), Murali Chintagumpala(Baylor College of Medicine), David M. Ashley(Royal Children's Hospital), Stewart J. Kellie(Children's Hospital at Westmead), Larry E. Kun(St. Jude Children's Research Hospital), Thomas E. Merchant(St. Jude Children's Research Hospital), Shaio Woo(Baylor College of Medicine), Greg Wheeler(Royal Children's Hospital), Valerie Ahern(Children's Hospital at Westmead), Matthew J. Krasin(St. Jude Children's Research Hospital), Maryam Fouladi(St. Jude Children's Research Hospital), Alberto Broniscer(St. Jude Children's Research Hospital), Robert A. Krance(Baylor College of Medicine), Gregory A. Hale(St. Jude Children's Research Hospital), Clinton F. Stewart(St. Jude Children's Research Hospital), Robert Dauser(Baylor College of Medicine), Robert A. Sanford(St. Jude Children's Research Hospital), Christine Fuller(St. Jude Children's Research Hospital), Ching C. Lau(Baylor College of Medicine), James M. Boyett(St. Jude Children's Research Hospital), Dana Wallace(St. Jude Children's Research Hospital), Richard J. Gilbertson(St. Jude Children's Research Hospital)
Cited by 948Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis